Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 31

Trial Status

Terminated1
Other2

Role Distribution

Other Roles3

Activity Timeline

Clinical Trials (3)

NCT05718882Not ApplicableTerminated
Lenvatinib Plus VIC-1911 in Lenvatinib-unresponsive or Lenvatinib-resistant HCC
Hepatocellular CarcinomaLiver CancerResistant Cancer
StudychairStart date: 2023-08-30
Transplantation for EASL-CLIF and APASL ACLF Patients: a Retrospective Cohort Study
Acute-On-Chronic Liver FailureLiver CirrhosisLiver Transplant; Complications
Studychair

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT05718882Not ApplicableStudyChair

Lenvatinib Plus VIC-1911 in Lenvatinib-unresponsive or Lenvatinib-resistant HCC

Hepatocellular CarcinomaLiver CancerResistant Cancer
Terminated
NCT05036031StudyChair

Transplantation for EASL-CLIF and APASL ACLF Patients: a Retrospective Cohort Study

Acute-On-Chronic Liver FailureLiver CirrhosisLiver Transplant; Complications
Unknown
NCT05322187Phase 2/3StudyChair

Sequential PD-1/PD-L1 Inhibitor and LENvatinib in TLCT and Refractory Hepatoblastoma After Chemotherapy

HepatoblastomaLiver CancerPediatric Cancer+2 more
Unknown

All 3 trials loaded